{"credit":[{"email":"afadaka@uwc.ac.za","name":"Adewale Oluwaseun Fadaka","typeEntity":"Person","typeRoles":[]}],"function":[{"operation":[{"term":"Pathway or network prediction","uri":"http://edamontology.org/operation_3439"},{"term":"Expression correlation analysis","uri":"http://edamontology.org/operation_3463"},{"term":"miRNA target prediction","uri":"http://edamontology.org/operation_0463"}]}],"labels":{"topic":[{"term":"Functional, regulatory and non-coding RNA","uri":"http://edamontology.org/topic_0659"},{"term":"Transcription factors and regulatory sites","uri":"http://edamontology.org/topic_0749"},{"term":"Oncology","uri":"http://edamontology.org/topic_2640"},{"term":"Gene transcripts","uri":"http://edamontology.org/topic_3512"},{"term":"Biomarkers","uri":"http://edamontology.org/topic_3360"}]},"publication":[{"doi":"10.3390/IJMS20205190","pmcid":"PMC6834124","pmid":"31635135"}],"summary":{"biotoolsCURIE":"biotools:SEECancer","biotoolsID":"SEECancer","description":"Functional Prediction of Candidate MicroRNAs for CRC Management Using in Silico Approach.\n\nClick evolutionary stage to quick search early late relapse metastasis drug resistant drug induced.\n\nCancer is driven by accumulating somatic alterations which confer normal cells fitness advantage to evolve from a premalignant status to malignant tumor. The SEECancer database presents the comprehensive cancer evolutionary stage-specific somatic events (including early-specific, late-specific, relapse-specific, metastasis-specific, drug-resistant and drug-induced genomic events) and their temporal orders.\n\n||| CORRECT NAME OF TOOL COULD ALSO BE 'GeneMANIA' (bio.tools/genemania), 'Trident', 'Mfold' (bio.tools/mfold), 'Cytoscape' (bio.tools/cytoscape)","homepage":"http://biocc.hrbmu.edu.cn/SEECancer/index.jsp","name":"SEECancer"}}